A comparative clinical efficacy of Sarpagandha ghan Vati and Mansyadi kwath in High Blood Pressure

Comparative clinical assessment of Sarpagandha Ghan Vati and Mansyadi Kwath in the management of Essential Hypertension:A randomized Parallel group study - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110404

Enrollment

200

Registered

2026-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for trial. 2. Patients in age-group between 30-60 yrs. 3. Patients suffering from stage-I hypertension (Systolic Blood pressure 140 159mm of Hg and diastolic blood pressure 90-99mm of Hg) 4. Hypertension associated with or without disturbed lipid profile 5. Both newly and previously diagnosed patients of hypertension will be included in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To assess the effect of both the drugs on Systolic blood pressure, Diastolic blood pressure, Mean arterial pressure and Pulse rate.Timepoint: patients will be assessed at baseline and at 15 days interval from starting the trial	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactRAJNIKANT ROHILA

R A PODAR AYURVEDIC COLLEGE MUMBAI

drmrevadkar@yahoo.com9757476325

Outcome results